| Id |
Subject |
Object |
Predicate |
Lexical cue |
db_id |
| 1894 |
0-11 |
ChemicalEntity |
denotes |
Dexrazoxane |
MESH:D064730 |
| 1895 |
29-45 |
DiseaseOrPhenotypicFeature |
denotes |
myelosuppression |
MESH:D001855 |
| 1896 |
84-93 |
ChemicalEntity |
denotes |
etoposide |
MESH:D005047 |
| 1897 |
98-110 |
ChemicalEntity |
denotes |
daunorubicin |
MESH:D003630 |
| 1898 |
119-130 |
ChemicalEntity |
denotes |
doxorubicin |
MESH:D004317 |
| 1899 |
145-159 |
ChemicalEntity |
denotes |
anthracyclines |
MESH:D018943 |
| 1900 |
160-172 |
ChemicalEntity |
denotes |
daunorubicin |
MESH:D003630 |
| 1901 |
177-188 |
ChemicalEntity |
denotes |
doxorubicin |
MESH:D004317 |
| 1902 |
197-215 |
ChemicalEntity |
denotes |
epipodophyllotoxin |
MESH:D011034 |
| 1903 |
216-225 |
ChemicalEntity |
denotes |
etoposide |
MESH:D005047 |
| 1904 |
318-334 |
DiseaseOrPhenotypicFeature |
denotes |
myelosuppression |
MESH:D001855 |
| 1905 |
339-355 |
DiseaseOrPhenotypicFeature |
denotes |
cardiac toxicity |
MESH:D066126 |
| 1906 |
373-384 |
ChemicalEntity |
denotes |
Dexrazoxane |
MESH:D064730 |
| 1907 |
386-394 |
ChemicalEntity |
denotes |
ICRF-187 |
MESH:D064730 |
| 1908 |
434-447 |
ChemicalEntity |
denotes |
anthracycline |
MESH:D018943 |
| 1909 |
456-470 |
DiseaseOrPhenotypicFeature |
denotes |
cardiotoxicity |
MESH:D066126 |
| 1910 |
530-550 |
DiseaseOrPhenotypicFeature |
denotes |
hematologic toxicity |
MESH:D006402 |
| 1911 |
581-592 |
ChemicalEntity |
denotes |
dexrazoxane |
MESH:D064730 |
| 1912 |
688-693 |
OrganismTaxon |
denotes |
human |
NCBITaxon:9606 |
| 1913 |
698-704 |
OrganismTaxon |
denotes |
murine |
NCBITaxon:10090 |
| 1914 |
731-740 |
ChemicalEntity |
denotes |
etoposide |
MESH:D005047 |
| 1915 |
742-754 |
ChemicalEntity |
denotes |
daunorubicin |
MESH:D003630 |
| 1916 |
760-771 |
ChemicalEntity |
denotes |
doxorubicin |
MESH:D004317 |
| 1917 |
776-787 |
ChemicalEntity |
denotes |
dexrazoxane |
MESH:D064730 |
| 1918 |
878-882 |
OrganismTaxon |
denotes |
mice |
NCBITaxon:10090 |
| 1919 |
901-910 |
ChemicalEntity |
denotes |
etoposide |
MESH:D005047 |
| 1920 |
912-924 |
ChemicalEntity |
denotes |
daunorubicin |
MESH:D003630 |
| 1921 |
930-941 |
ChemicalEntity |
denotes |
doxorubicin |
MESH:D004317 |
| 1922 |
959-970 |
ChemicalEntity |
denotes |
dexrazoxane |
MESH:D064730 |
| 1923 |
1081-1092 |
ChemicalEntity |
denotes |
dexrazoxane |
MESH:D064730 |
| 1924 |
1101-1117 |
DiseaseOrPhenotypicFeature |
denotes |
myelosuppression |
MESH:D001855 |
| 1925 |
1122-1133 |
DiseaseOrPhenotypicFeature |
denotes |
weight loss |
MESH:D015431 |
| 1926 |
1139-1151 |
ChemicalEntity |
denotes |
daunorubicin |
MESH:D003630 |
| 1927 |
1156-1165 |
ChemicalEntity |
denotes |
etoposide |
MESH:D005047 |
| 1928 |
1169-1173 |
OrganismTaxon |
denotes |
mice |
NCBITaxon:10090 |
| 1929 |
1252-1263 |
ChemicalEntity |
denotes |
dexrazoxane |
MESH:D064730 |
| 1930 |
1280-1296 |
DiseaseOrPhenotypicFeature |
denotes |
myelosuppression |
MESH:D001855 |
| 1931 |
1298-1309 |
DiseaseOrPhenotypicFeature |
denotes |
weight loss |
MESH:D015431 |
| 1932 |
1328-1340 |
DiseaseOrPhenotypicFeature |
denotes |
cytotoxicity |
MESH:D064420 |
| 1933 |
1346-1357 |
ChemicalEntity |
denotes |
doxorubicin |
MESH:D004317 |
| 1934 |
1422-1433 |
ChemicalEntity |
denotes |
dexrazoxane |
MESH:D064730 |
| 1935 |
1499-1510 |
ChemicalEntity |
denotes |
doxorubicin |
MESH:D004317 |
| 1936 |
1548-1560 |
ChemicalEntity |
denotes |
daunorubicin |
MESH:D003630 |
| 1937 |
1718-1727 |
ChemicalEntity |
denotes |
etoposide |
MESH:D005047 |
| 1938 |
1778-1789 |
ChemicalEntity |
denotes |
dexrazoxane |
MESH:D064730 |
| 1939 |
1830-1840 |
DiseaseOrPhenotypicFeature |
denotes |
metastases |
MESH:D009362 |
| 1940 |
1851-1862 |
ChemicalEntity |
denotes |
dexrazoxane |
MESH:D064730 |
| 1941 |
1881-1890 |
ChemicalEntity |
denotes |
etoposide |
MESH:D005047 |
| 1942 |
1957-1977 |
DiseaseOrPhenotypicFeature |
denotes |
hematologic toxicity |
MESH:D006402 |
| 1943 |
2082-2091 |
DiseaseOrPhenotypicFeature |
denotes |
cytotoxic |
MESH:D064420 |
